EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Global Insulin Delivery Devices Market Forecast to 2017

  • ID: 2568608
  • Report
  • June 2013
  • Region: Global
  • 90 Pages
  • RNCOS E-Services Private Limited
1 of 4

FEATURED COMPANIES

  • Becton Dickinson
  • Eli Lilly
  • F. Hoffmann La Roche
  • Medtronic
  • Novo Nordisk
  • Sanofi-Aventis
  • MORE
371 Million people had diabetes in 2012 and by 2030 this number is expected to rise to 552 Million. This finding by International Diabetes Federation (IDF) and similar results from studies done by organizations of repute like WHO, CDC, NHS etc. suggest that a huge patient population exists for the diabetes healthcare market. It is estimated that in 2011, around US$ 465 Billion were spent on healthcare expenditures related to diabetes. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study.

In latest research study, “Global Insulin Delivery Devices Market Forecast to 2017”, the company's analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 8.8 Billion in 2012, is expected to grow at a CAGR of 8.5% during 2012-2017.

Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of delivery devices' market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth and its future outlook.

The analysis will help the reader to assess the current market penetration of various devices in different regions, which varies significantly due to consumer preferences, and seeks viable business opportunities. For instance, our research revealed that while insulin reusable pens were mostly popular in China and represented one of the most exciting growth areas, insulin syringes market was all set to grow in the regions of India and Brazil.

This study leads to the proposition that innovation has huge scope in this field and its analysts have advertently elaborated some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, Becton, Dickinson and Company that together account for more than 90% of the global market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Becton Dickinson
  • Eli Lilly
  • F. Hoffmann La Roche
  • Medtronic
  • Novo Nordisk
  • Sanofi-Aventis
  • MORE
1. Analyst View

2. Research Methodology

3. Global Insulin Market Overview to 2017

4. Key Market Drivers

5. Global Insulin Delivery Devices Market Outlook to 2017
5.1 US
5.1.1 Prevalence
5.1.2 Market Analysis
5.2 Japan
5.2.1 Prevalence
5.2.2 Market Analysis
5.3 China
5.3.1 Prevalence
5.3.2 Market Analysis
5.4 Brazil
5.4.1 Prevalence
5.4.2 Market Analysis
5.5 India
5.5.1 Prevalence
5.5.2 Market Analysis

6. Insulin Delivery Devices: Current and Future Outlook to 2017
6.1 Insulin Pens
6.1.1 Mechanism and Technologies
6.1.2 Pros and Cons
6.1.3 Market Analysis
6.1.4 Key Players and Products
6.2 Insulin Pumps
6.2.1 Mechanism and Technologies
6.2.2 Pros and Cons
6.2.3 Market Analysis
6.2.4 Key Players and Products
6.3 Insulin Syringes
6.3.1 Mechanism and Technologies
6.3.2 Pros and Cons
6.3.3 Market Analysis
6.3.4 Key Players and Products
6.4 Insulin Jet Injectors
6.4.1 Mechanism and Technologies
6.4.2 Pros and Cons
6.4.3 Market Analysis
6.4.4 Key Players and Products

7. Emerging Devices
7.1 Implantable Insulin Pumps
7.2 Insulin Inhalers
7.3 Oral Insulin/Insulin Pill
7.4 Insulin Patch

8. Key Players
8.1 Novo Nordisk
8.2 Eli Lilly
8.3 Medtronic
8.4 Becton Dickinson
8.5 Sanofi-Aventis
8.6 F. Hoffmann La Roche

List of Tables

Table 3-1: Global - Diabetic Population of Top 10 Countries (Million), 2012 & 2030
Table 5-1: US - Diabetic Patients in Age Group 20-79 Years ('000), 2012 & 2030
Table 5-2: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2012 & 2030
Table 5-3: China - Diabetic Patients in Age Group 20-79 Years ('000), 2012 & 2030
Table 5-4: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2012 & 2030
Table 5-5: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2012 & 2030
Table 6-1: Global - Key Insulin Pen Products by Company
Table 6-2: Global - Key Insulin Syringes Product by Company

List of Charts

Figure 3-1: Global - Number of Diabetic Patients (Million), 2012 & 2030
Figure 3-2: Global - Insulin Market (Billion US$), 2012-2017
Figure 3-3: Global - Insulin Market by Type of Packaging (%), 2012
Figure 3-4: Global - Insulin Market by Region (%), 2012
Figure 3-5: Global - Insulin Market by Player (%), 2012
Figure 5-1: Global - Insulin Delivery Devices Market (Billion US$), 2012-2017
Figure 5-2: Global - Insulin Delivery Devices Market by Segment (%), 2012
Figure 5-3: US - Insulin Delivery Devices Market (Billion US$), 2012-2017
Figure 5-4: US - Insulin Delivery Devices Market by Segment (%), 2012
Figure 5-5: US - Insulin Delivery Devices Market by Segment (%), 2017
Figure 5-6: US - Insulin Pen Market (Billion US$), 2012-2017
Figure 5-7: US - Insulin Syringe Market (Million US$), 2012-2017
Figure 5-8: US - Insulin Pump Market (Million US$), 2012-2017
Figure 5-9: US - Insulin Jet Injector Market (Million US$), 2012-2017
Figure 5-10: Japan - Insulin Delivery Devices Market (Billion US$), 2012-2017
Figure 5-11: Japan - Insulin Pen Market (Million US$), 2012-2017
Figure 5-12: Japan - Insulin Syringe Market (Million US$), 2012-2017
Figure 5-13: China - Insulin Delivery Devices Market (Million US$), 2012-2017
Figure 5-14: China - Insulin Pen Market (Million US$), 2012-2017
Figure 5-15: China - Insulin Syringe Market (Million US$), 2012-2017
Figure 5-16: Brazil - Insulin Delivery Devices Market (Million US$), 2012-2017
Figure 5-17: Brazil - Insulin Pen Market (Million US$), 2012-2017
Figure 5-18: Brazil - Insulin Syringe Market (Million US$), 2012-2017
Figure 5-19: India - Insulin Delivery Devices Market (Million US$), 2012-2017
Figure 5-20: India - Insulin Pen Market (Million US$), 2012-2017
Figure 5-21: India - Insulin Syringe Market (Million US$), 2012-2017
Figure 6-1: Global - Insulin Pen Market (Billion US$), 2012-2017\
Figure 6-2: Global - Insulin Pen Market by Region (%), 2012
Figure 6-3: Global - Insulin Pen Market by Region (%), 2017
Figure 6-4: Global - Insulin Pump Market (Million US$), 2012-2017
Figure 6-5: Global - Share of Medtronic in Insulin Pumps Market (2010)
Figure 6-6: Global - Insulin Syringes Market (Million US$), 2012-2017
Figure 6-7: Global - Insulin Syringes Market by Region (%), 2012
Figure 6-8: Global - Insulin Syringes Market by Region (%), 2017
Figure 6-9: Global - Insulin Jet Injectors Market (Million US$), 2012-2017
Note: Product cover images may vary from those shown
3 of 4
- Novo Nordisk
- Eli Lilly
- Medtronic
- Becton Dickinson
- Sanofi-Aventis
- F. Hoffmann La Roche
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll